A new generation of efficient drugs for the modulation of the insulin biosynthesis

Extensive research into the very core of the so-called “lifestyle” disease diabetes mellitus type 2 has enabled the identification of three target proteins and their link to the pancreatic duodenal homeobox-1 protein (PDX-1), crucial for the insulin biosynthesis process. Their identification enables novel ways for research to develop new drugs for influencing the bodily function to produce insulin.

Further Information: PDF

PVA Mecklenburg-Vorpommern AG
Phone: +49 (0)381/49 74 74 0

Contact
Antonio Martinez

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

A universal framework for spatial biology

SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…

How complex biological processes arise

A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…

Airborne single-photon lidar system achieves high-resolution 3D imaging

Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…

Partners & Sponsors